136 related articles for article (PubMed ID: 15855321)
1. The contribution of visceral adipose tissue to splanchnic cortisol production in healthy humans.
Andrew R; Westerbacka J; Wahren J; Yki-Järvinen H; Walker BR
Diabetes; 2005 May; 54(5):1364-70. PubMed ID: 15855321
[TBL] [Abstract][Full Text] [Related]
2. Cortisol release from adipose tissue by 11beta-hydroxysteroid dehydrogenase type 1 in humans.
Stimson RH; Andersson J; Andrew R; Redhead DN; Karpe F; Hayes PC; Olsson T; Walker BR
Diabetes; 2009 Jan; 58(1):46-53. PubMed ID: 18852329
[TBL] [Abstract][Full Text] [Related]
3. Body fat distribution and cortisol metabolism in healthy men: enhanced 5beta-reductase and lower cortisol/cortisone metabolite ratios in men with fatty liver.
Westerbacka J; Yki-Järvinen H; Vehkavaara S; Häkkinen AM; Andrew R; Wake DJ; Seckl JR; Walker BR
J Clin Endocrinol Metab; 2003 Oct; 88(10):4924-31. PubMed ID: 14557475
[TBL] [Abstract][Full Text] [Related]
4. Tissue production of cortisol by 11beta-hydroxysteroid dehydrogenase type 1 and metabolic disease.
Walker BR; Andrew R
Ann N Y Acad Sci; 2006 Nov; 1083():165-84. PubMed ID: 17148739
[TBL] [Abstract][Full Text] [Related]
5. Increased in vivo regeneration of cortisol in adipose tissue in human obesity and effects of the 11beta-hydroxysteroid dehydrogenase type 1 inhibitor carbenoxolone.
Sandeep TC; Andrew R; Homer NZ; Andrews RC; Smith K; Walker BR
Diabetes; 2005 Mar; 54(3):872-9. PubMed ID: 15734867
[TBL] [Abstract][Full Text] [Related]
6. Splanchnic cortisol production in dogs occurs primarily in the liver: evidence for substantial hepatic specific 11beta hydroxysteroid dehydrogenase type 1 activity.
Basu R; Edgerton DS; Singh RJ; Cherrington A; Rizza RA
Diabetes; 2006 Nov; 55(11):3013-9. PubMed ID: 17065337
[TBL] [Abstract][Full Text] [Related]
7. Increased whole-body and sustained liver cortisol regeneration by 11beta-hydroxysteroid dehydrogenase type 1 in obese men with type 2 diabetes provides a target for enzyme inhibition.
Stimson RH; Andrew R; McAvoy NC; Tripathi D; Hayes PC; Walker BR
Diabetes; 2011 Mar; 60(3):720-5. PubMed ID: 21266326
[TBL] [Abstract][Full Text] [Related]
8. Splanchnic cortisol production occurs in humans: evidence for conversion of cortisone to cortisol via the 11-beta hydroxysteroid dehydrogenase (11beta-hsd) type 1 pathway.
Basu R; Singh RJ; Basu A; Chittilapilly EG; Johnson CM; Toffolo G; Cobelli C; Rizza RA
Diabetes; 2004 Aug; 53(8):2051-9. PubMed ID: 15277385
[TBL] [Abstract][Full Text] [Related]
9. Acute in vivo regulation of 11beta-hydroxysteroid dehydrogenase type 1 activity by insulin and intralipid infusions in humans.
Wake DJ; Homer NZ; Andrew R; Walker BR
J Clin Endocrinol Metab; 2006 Nov; 91(11):4682-8. PubMed ID: 16954164
[TBL] [Abstract][Full Text] [Related]
10. Effects of peroxisome proliferator-activated receptor-alpha and -gamma agonists on 11beta-hydroxysteroid dehydrogenase type 1 in subcutaneous adipose tissue in men.
Wake DJ; Stimson RH; Tan GD; Homer NZ; Andrew R; Karpe F; Walker BR
J Clin Endocrinol Metab; 2007 May; 92(5):1848-56. PubMed ID: 17327378
[TBL] [Abstract][Full Text] [Related]
11. Local and systemic impact of transcriptional up-regulation of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue in human obesity.
Wake DJ; Rask E; Livingstone DE; Söderberg S; Olsson T; Walker BR
J Clin Endocrinol Metab; 2003 Aug; 88(8):3983-8. PubMed ID: 12915696
[TBL] [Abstract][Full Text] [Related]
12. Recycling between cortisol and cortisone in human splanchnic, subcutaneous adipose, and skeletal muscle tissues in vivo.
Hughes KA; Manolopoulos KN; Iqbal J; Cruden NL; Stimson RH; Reynolds RM; Newby DE; Andrew R; Karpe F; Walker BR
Diabetes; 2012 Jun; 61(6):1357-64. PubMed ID: 22511204
[TBL] [Abstract][Full Text] [Related]
13. Effect of nutrient ingestion on total-body and splanchnic cortisol production in humans.
Basu R; Singh R; Basu A; Johnson CM; Rizza RA
Diabetes; 2006 Mar; 55(3):667-74. PubMed ID: 16505229
[TBL] [Abstract][Full Text] [Related]
14. Liver is the site of splanchnic cortisol production in obese nondiabetic humans.
Basu R; Basu A; Grudzien M; Jung P; Jacobson P; Johnson M; Singh R; Sarr M; Rizza RA
Diabetes; 2009 Jan; 58(1):39-45. PubMed ID: 18852327
[TBL] [Abstract][Full Text] [Related]
15. Obesity and type 2 diabetes do not alter splanchnic cortisol production in humans.
Basu R; Singh RJ; Basu A; Chittilapilly EG; Johnson MC; Toffolo G; Cobelli C; Rizza RA
J Clin Endocrinol Metab; 2005 Jul; 90(7):3919-26. PubMed ID: 15811928
[TBL] [Abstract][Full Text] [Related]
16. Tissue-specific dysregulation of cortisol metabolism in human obesity.
Rask E; Olsson T; Söderberg S; Andrew R; Livingstone DE; Johnson O; Walker BR
J Clin Endocrinol Metab; 2001 Mar; 86(3):1418-21. PubMed ID: 11238541
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 in obesity.
Wake DJ; Walker BR
Endocrine; 2006 Feb; 29(1):101-8. PubMed ID: 16622297
[TBL] [Abstract][Full Text] [Related]
18. 11β-Hydroxysteroid dehydrogenase activity in the brain does not contribute to systemic interconversion of cortisol and cortisone in healthy men.
Kilgour AH; Semple S; Marshall I; Andrews P; Andrew R; Walker BR
J Clin Endocrinol Metab; 2015 Feb; 100(2):483-9. PubMed ID: 25393644
[TBL] [Abstract][Full Text] [Related]
19. In vivo activity of 11beta-hydroxysteroid dehydrogenase type 1 and free fatty acid-induced insulin resistance.
Mai K; Kullmann V; Bobbert T; Maser-Gluth C; Möhlig M; Bähr V; Pfeiffer AF; Spranger J; Diederich S
Clin Endocrinol (Oxf); 2005 Oct; 63(4):442-9. PubMed ID: 16181237
[TBL] [Abstract][Full Text] [Related]
20. 11 beta-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome.
Wake DJ; Walker BR
Mol Cell Endocrinol; 2004 Feb; 215(1-2):45-54. PubMed ID: 15026174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
